ArticleAntimicrobial agents and chemotherapy2016

Reduction in Tedizolid Plasma Exposure among End-Stage Renal Disease Patients Undergoing Dialysis Is Explained by Variations in Ideal Body Weight.

Shawn Flanagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.